Efficacy of 0.05% Epinastine and 0.1% Olopatadine for Allergic Conjunctivitis as Seasonal and Preseasonal Treatment

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s141279
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Informa UK Limited

Related search

Comparative Study of Olopatadine 0.1% and Lodoxamide 0.1% in Treatment of Seasonal Allergic Conjunctivitis

Annals of the College of Medicine, Mosul
2010English

Olopatadine/Mometasone Combination Nasal Spray for the Treatment of Seasonal Allergic Rhinitis: A Pooled Analysis of Efficacy and Safety

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

A Prospective Study of Efficacy and Safety of Olopatadine Versus Azelastine in Allergic Conjunctivitis at a Tertiary Care Hospital

International Journal of Basic & Clinical Pharmacology
2017English

Efficacy of Montelukast and Levocetirizine as Treatment for Allergic Rhinitis

Journal of Allergy & Therapy
2010English

Correlation of Features of Allergic Rhinitis and Allergic Conjunctivitis With Treatment Modalities

Journal of Advances in Medicine and Medical Research
2019English

Epinastine Hydrochloride for Pediatric Allergic Rhinitis

Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2011English

Ocular Tolerability and Efficacy of Ebastine Colloidal Formulation in Allergic Conjunctivitis

International Journal of Pharmaceutical Sciences and Drug Research
2019English

Allergic Conjunctivitis

Journal of Allergy
1941English

Retrospective Review on the Use of Topical Cyclosporin a 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy